The UK has ordered 100 million doses from the manufacturer AstraZeneca.
A coronavirus vaccine developed by drug firm AstraZeneca and Oxford University has been approved for use in Britain, the government announced on Wednesday, paving the way for a mass rollout.
A government spokesman said it has accepted a recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) “to authorise Oxford University/AstraZeneca’s Covid-19 vaccine for use”, making Britain the first nation to approve the jab.
The UK has ordered 100 million doses from the manufacturer AstraZeneca – enough to vaccinate 50 million people.
The Oxford-AstraZeneca vaccine was designed in the first months of 2020, tested on the first volunteer in April, and has since been through large-scale clinical trials involving thousands of people.